Published in Cardiovascular Device Liability Week, January 15th, 2006
"Treatment of severe epistaxis can encompass many modalities. Control rates with all treatments are good," scientists in the United States report.
"Morbidity among treatment groups varies. Angiographic embolization is one such method that has a very low complication rate. Over the last 10 years, it has become the preferred treatment at our institution," wrote N.P. Christensen and colleagues, Oregon Health Science University.
According to the researchers, the study design included, "Tertiary medical referral centers: OHSU, Portland VAMC. Retrospective review of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.